🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 8 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 9,95 10,08 9,82 9,89 -1,59% 2,60% 2.741.100
01/02/2024 10,06 10,38 9,92 10,05 +0,50% 4,57% 5.347.800
31/01/2024 10,30 10,40 10,00 10,00 -2,15% 3,88% 4.852.400
30/01/2024 10,30 10,30 10,00 10,22 -0,97% 2,96% 9.993.300
29/01/2024 10,33 10,43 10,00 10,32 -0,48% 4,16% 26.870.400
26/01/2024 10,54 10,65 10,35 10,37 -1,43% 2,89% 4.582.800
25/01/2024 10,46 10,63 10,38 10,52 +1,15% 2,37% 2.640.300
24/01/2024 10,47 10,60 10,38 10,40 -0,48% 2,05% 2.798.300
23/01/2024 10,31 10,59 10,31 10,45 +0,97% 2,76% 4.795.700
22/01/2024 10,39 10,65 10,19 10,35 +0,00% 4,43% 4.885.300
19/01/2024 10,48 10,49 10,25 10,35 -1,52% 2,29% 3.933.200
18/01/2024 10,85 10,85 10,36 10,51 -2,32% 4,52% 4.342.500
17/01/2024 10,69 10,97 10,57 10,76 -0,92% 3,74% 5.595.400
16/01/2024 11,08 11,19 10,83 10,86 -1,81% 3,25% 3.325.100
12/01/2024 11,03 11,31 10,96 11,06 +0,64% 3,17% 2.331.200
11/01/2024 11,03 11,23 10,84 10,99 -1,61% 3,49% 3.944.200
10/01/2024 11,50 11,53 10,93 11,17 -1,59% 5,22% 4.600.600
09/01/2024 11,35 11,71 11,23 11,35 -0,79% 4,27% 6.013.100
08/01/2024 11,10 11,45 10,84 11,44 +1,51% 5,50% 5.283.700
05/01/2024 11,00 11,56 10,97 11,27 +4,16% 5,36% 7.796.700
04/01/2024 10,86 10,99 10,73 10,82 -0,37% 2,44% 5.416.200
03/01/2024 11,19 11,23 10,80 10,86 -4,32% 3,84% 3.748.700
02/01/2024 11,22 11,49 11,05 11,35 +1,07% 3,92% 3.727.200
29/12/2023 11,37 11,39 11,07 11,23 -1,23% 2,81% 4.193.200
28/12/2023 11,61 11,65 11,21 11,37 -1,81% 3,75% 4.722.100
27/12/2023 11,60 11,78 11,39 11,58 +0,96% 3,41% 4.582.800
26/12/2023 11,00 11,50 10,98 11,47 +5,33% 4,73% 8.764.500
22/12/2023 10,59 11,04 10,59 10,89 +3,32% 4,25% 4.579.800
21/12/2023 10,41 10,62 10,33 10,54 +5,82% 2,80% 8.185.400
20/12/2023 10,30 10,51 9,94 9,96 -7,78% 5,49% 7.879.700